_cirrhosis-causes-symptoms-diagnosis-treatment-pathology-preview-1.jpg "Cirrhosis - causes, symptoms, diagnosis, treatment, pathology from fibrosis of the liver stage 1 Video Screenshot Preview 1")
Gallery_cirrhosis-causes-symptoms-diagnosis-treatment-pathology-preview-3.jpg "Cirrhosis - causes, symptoms, diagnosis, treatment, pathology from fibrosis of the liver stage 1 Video Screenshot Preview 3")
Gallery_cirrhosis-causes-symptoms-diagnosis-treatment-pathology-preview-hqdefault.jpg "Cirrhosis - causes, symptoms, diagnosis, treatment, pathology from fibrosis of the liver stage 1 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 9 minutes 48 seconds
👁 View: 733.4K times
Play Audio:👁 View: 733.4K times
Description:
Osmosis from Elsevier
Osmosis from Elsevier
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_liver-health-amp-diabetes.webp "Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It is highly prevalent and is associated with significant adverse outcomes and is closely associated with type 2 diabetes and obesity, and both of these conditions drive progressive disease toward the more advanced stages. The ability to make an accurate assessment of disease stage can also be challenging. Liver")
_liver-fibrosis-stages-and-symptoms.webp "HEALTHY FIT")
_how-dangerous-is-liver-fibrosis.webp "Wander Woman")
_live-virtual-symposium-a-deeper-dive-into-nash-diagnosis-and-treatment-an-augmented-reality-experience.webp "Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Disease models project that the number of individuals with end-stage liver disease will double -")
⏲ 81 min 39 sec ✓ 22-Apr-2020
_how-long-can-you-live-after-being-diagnosed-with-cirrhosis-of-the-liver.webp "Yashoda Hospitals - Hyderabad")
_hepatic-cirrhosis-124-2-minute-gastroenterology-124-medicine-video-124-v-learning-124-sqadia-com.webp "This short clip of Gastroenterology explains the pathophysiology of cirrhosis of the liver. Hepatic cirrhosis is defined histologically as a diffuse hepatic process characterized by fibrosis and conversion of normal liver architecture into structurally abnormal nodules. It may take weeks to years to occur.nn----------------------------------------nGastroenterology Medicine Lectures Collection -nhttps://www.sqadia.com/categories/medicine-gastroenterologyn----------------------------------------")
⏲ 1 min 35 sec ✓ 17-Aug-2020
_resmetirom-for-nash-with-liver-fibrosis-124-nejm.webp "NEJM Group")
_compassionate-treatment-for-end-stage-liver-disease-124-ohio-state-medical-center.webp "Ohio State Wexner Medical Center")
⏲ 1 minute 25 seconds 👁 25.2K
_liver-health-amp-diabetes.jpg)
_liver-fibrosis-stages-and-symptoms.jpg)
_how-dangerous-is-liver-fibrosis.jpg)
_live-virtual-symposium-a-deeper-dive-into-nash-diagnosis-and-treatment-an-augmented-reality-experience.jpg)
_how-long-can-you-live-after-being-diagnosed-with-cirrhosis-of-the-liver.jpg)
_hepatic-cirrhosis-124-2-minute-gastroenterology-124-medicine-video-124-v-learning-124-sqadia-com.jpg)
_resmetirom-for-nash-with-liver-fibrosis-124-nejm.jpg)
_compassionate-treatment-for-end-stage-liver-disease-124-ohio-state-medical-center.jpg)
![[+]](/images/menu.gif){kind=small}